Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Silence Therapeutics plc
| Metric | Silence Therapeutics plc SLNHealthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $559,000 |
| Net income (latest) | −$89M |
| Operating margin | −16292.8% |
| Net margin | −15851.9% |
| Return on equity | −142.2% |
| Return on assets | −67.4% |
| Return on capital (ROCE) | −77.3% |
| Debt / equity | 1.11× |
| Revenue growth (YoY) | −98.7% |
| Altman Z″ (distress) | -12.42 |
| Accruals / assets | −20.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.